Embed

Academic

Authors

Ari D. Baron

Ari D. Baron,University of California San Francisco,Oncology

Edit

Ari D. Baron

University of California San Francisco

Publications: 4 | Citations: 2683

Fields: Oncology

Collaborated with 50 co-authors from 2004 to 2009 | Cited by 9849 authors

Cumulative Annual

Sort by:

Publications (4)

BibTeX | RIS | RefWorks Download

Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia (Citations: 9)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=31691441&selfId1=25803637&selfId2=0&maxNumber=12&query=

Journal: Clinical Cancer Research - CLIN CANCER RES , vol. 15, no. 1, pp. 355-360, 2009

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study (Citations: 27)

, , , , , , ,

Journal: Cancer , vol. 110, no. 5, pp. 965-972, 2007

A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma (Citations: 7)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=33220325&selfId1=25803637&selfId2=0&maxNumber=12&query=

Journal: Lung Cancer , vol. 54, no. 1, pp. 69-77, 2006

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer (Citations: 2640)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=30050069&selfId1=25803637&selfId2=0&maxNumber=12&query=

Journal: New England Journal of Medicine - N ENGL J MED , vol. 350, no. 23, pp. 2335-2342, 2004

Sort by:

Citations (2683 times by 2683 publications)

Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension

, , , , , , , , ,

Journal: PLOS One , vol. 7, no. 6, 2012

Malnutrition Is High and Underestimated During Chemotherapy in Gastrointestinal Cancer: An AGEO Prospective Cross-Sectional Multicenter Study

, , , , , , , , ,

Journal: Nutrition and Cancer-an International Journal - NUTR CANCER , vol. ahead-of-p, no. ahead-of-p, 2012

In Vivo Evolution of Tumor-Derived Endothelial Cells

, , , ,

Journal: PLOS One , vol. 7, no. 5, 2012

Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis

, ,

Journal: Nature Reviews Rheumatology - NAT REV RHEUMATOL , vol. 8, no. 3, pp. 153-162, 2012

Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells

, , , , , ,

Journal: PLOS One , vol. 7, no. 3, 2012

Comments

Co-authors (50)

Journals (4)

Keywords (11)

Ari D. Baron,University of California San Francisco,Oncology

Publications (4)

BibTeX | RIS | RefWorks Download

Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia (Citations: 9)

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study (Citations: 27)

A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma (Citations: 7)

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer (Citations: 2640)

Citations (2683 times by 2683 publications)

Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension

Malnutrition Is High and Underestimated During Chemotherapy in Gastrointestinal Cancer: An AGEO Prospective Cross-Sectional Multicenter Study

In Vivo Evolution of Tumor-Derived Endothelial Cells

Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis

Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells


	View FAQ about top research areas and Fields of study

Ari D. Baron,University of California San Francisco,Oncology

Publications (4) BibTeX | RIS | RefWorks Download

Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia (Citations: 9)

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study (Citations: 27)

A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma (Citations: 7)

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer (Citations: 2640)

Publications (4)

BibTeX | RIS | RefWorks Download